Crown Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.4M Sell
2,939
-252
-8% -$297K 0.84% 21
2026
Q2
$3.83M Buy
3,191
+13
+0.4% +$13.3K 0.97% 20
2026
Q1
$2.92M Sell
3,178
-87
-3% -$88.2K 0.86% 24
2025
Q4
$3.51M Buy
3,265
+184
+6% +$176K 0.98% 21
2025
Q3
$2.35M Sell
3,081
-136
-4% -$101K 0.71% 25
2025
Q2
$2.51M Sell
3,217
-65
-2% -$50.5K 0.94% 21
2025
Q1
$2.71M Buy
3,282
+187
+6% +$156K 1.41% 17
2024
Q4
$2.39M Buy
3,095
+54
+2% +$44.7K 0.97% 20
2024
Q3
$2.69M Sell
3,041
-205
-6% -$184K 1.17% 19
2024
Q2
$2.94M Buy
3,246
+134
+4% +$107K 1.47% 16
2024
Q1
$2.42M Sell
3,112
-53
-2% -$37.7K 1.25% 18
2023
Q4
$1.85M Buy
3,165
+569
+22% +$332K 1.11% 18
2023
Q3
$1.39M Sell
2,596
-26
-1% -$13.4K 1.05% 17
2023
Q2
$1.23M Sell
2,622
-14
-0.5% -$5.87K 0.97% 17
2023
Q1
$905K Sell
2,636
-66
-2% -$22.3K 0.76% 21
2022
Q4
$988K Buy
2,702
+894
+49% +$317K 0.93% 18
2022
Q3
$585K Sell
1,808
-107
-6% -$33.9K 0.6% 26
2022
Q2
$621K Buy
1,915
+63
+3% +$18.9K 0.56% 31
2022
Q1
$530K Buy
+1,852
New +$477K 0.37% 46

Other funds holding LLY

Crown Wealth Group's LLY Position: Q3 2026 in Review

Crown Wealth Group reduced its Eli Lilly (LLY) stake by 7.9% in Q3 2026, selling an estimated $297K and leaving 2,939 shares worth $3.4M. The position accounts for 0.84% of the portfolio, ranked #21.

Crown Wealth Group first reported a position in LLY in Q1 2022 and has held it in 19 quarters since. The position peaked at $3.83M in Q2 2026. 1,995 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Crown Wealth Group held 2,939 shares of Eli Lilly worth $3.4M as of Q3 2026.
  • Crown Wealth Group sold 252 Eli Lilly shares in Q3 2026, an estimated $297K.
  • Eli Lilly made up 0.84% of Crown Wealth Group's portfolio in Q3 2026, its #21 holding.
  • Crown Wealth Group first reported a position in Eli Lilly in Q1 2022 and has held it in 19 quarters since.
  • Crown Wealth Group's Eli Lilly position peaked at $3.83M in Q2 2026.
  • 1,995 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Crown Wealth Group's 13F filing for Q3 2026, filed 19 Oct 2026.